Schroder Investment Management Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,611
| Closed | -$877K | – | 1169 |
|
|
2025
Q1 | $877K | Sell |
3,611
-176
| -5% | -$52.9K | ﹤0.01% | 1011 |
|
|
2024
Q4 | $1.24M | Buy |
3,787
+322
| +9% | +$109K | ﹤0.01% | 988 |
|
|
2024
Q3 | $1.15M | Buy |
3,465
+49
| +1% | +$15.6K | ﹤0.01% | 1014 |
|
|
2024
Q2 | $933K | Sell |
3,416
-753
| -18% | -$219K | ﹤0.01% | 1039 |
|
|
2024
Q1 | $1.44M | Buy |
4,169
+1,021
| +32% | +$336K | ﹤0.01% | 970 |
|
|
2023
Q4 | $1.02M | Buy |
3,148
+522
| +20% | +$164K | ﹤0.01% | 1008 |
|
|
2023
Q3 | $941K | Buy |
2,626
+543
| +26% | +$210K | ﹤0.01% | 1022 |
|
|
2023
Q2 | $790K | Buy |
2,083
+836
| +67% | +$340K | ﹤0.01% | 1078 |
|
|
2023
Q1 | $597K | Buy |
1,247
+18
| +1% | +$8.43K | ﹤0.01% | 1119 |
|
|
2022
Q4 | $517K | Buy |
1,229
+9
| +0.7% | +$3.63K | ﹤0.01% | 1139 |
|
|
2022
Q3 | $509K | Buy |
+1,220
| New | +$608K | ﹤0.01% | 1144 |
|
|
2022
Q1 | – | Sell |
-193
| Closed | -$14K | – | 1363 |
|
|
2021
Q4 | $14K | Buy |
193
+13
| +7% | +$9.73K | ﹤0.01% | 1366 |
|
|
2021
Q3 | $134K | Buy |
180
+154
| +592% | +$115K | ﹤0.01% | 1373 |
|
|
2021
Q2 | $17K | Sell |
26
-10
| -28% | -$6.09K | ﹤0.01% | 1463 |
|
|
2021
Q1 | $21K | Buy |
+36
| New | +$21.3K | ﹤0.01% | 1455 |
|
|
2020
Q4 | – | Sell |
-7,023
| Closed | -$3.59M | – | 1449 |
|
|
2020
Q3 | $3.59M | Sell |
7,023
-212
| -3% | -$107K | 0.01% | 783 |
|
|
2020
Q2 | $3.27M | Hold |
7,235
| – | – | 0.01% | 741 |
|
|
2020
Q1 | $2.76M | Buy |
7,235
+14
| +0.2% | +$5.15K | 0.01% | 759 |
|
|
2019
Q4 | $2.67M | Sell |
7,221
-18
| -0.2% | -$6.35K | ﹤0.01% | 833 |
|
|
2019
Q3 | $2.42M | Sell |
7,239
-6,833
| -49% | -$2.23M | ﹤0.01% | 861 |
|
|
2019
Q2 | $4.4M | Buy |
14,072
+7,036
| +100% | +$2.11M | ﹤0.01% | 821 |
|
|
2019
Q1 | $2.15M | Buy |
7,036
+2,470
| +54% | +$667K | ﹤0.01% | 804 |
|
|
2018
Q4 | $1.06M | Hold |
4,566
| – | – | ﹤0.01% | 860 |
|
|
2018
Q3 | $1.43M | Hold |
4,566
| – | – | ﹤0.01% | 857 |
|
|
2018
Q2 | $1.32M | Hold |
4,566
| – | – | ﹤0.01% | 883 |
|
|
2018
Q1 | $1.14M | Hold |
4,566
| – | – | ﹤0.01% | 926 |
|
|
2017
Q4 | $1.09M | Sell |
4,566
-19,166
| -81% | -$4.64M | ﹤0.01% | 965 |
|
|
2017
Q3 | $5.28M | Buy |
23,732
+18,835
| +385% | +$4.24M | 0.01% | 751 |
|
|
2017
Q2 | $1.1M | Sell |
4,897
-238
| -5% | -$51.9K | ﹤0.01% | 954 |
|
|
2017
Q1 | $1.02M | Buy |
+5,135
| New | +$989K | ﹤0.01% | 953 |
|
|
2014
Q2 | – | Sell |
-1,300
| Closed | -$167K | – | 1381 |
|
|
2014
Q1 | $167K | Hold |
1,300
| – | – | ﹤0.01% | 1185 |
|
|
2013
Q4 | $161K | Sell |
1,300
-1,500
| -54% | -$183K | ﹤0.01% | 1242 |
|
|
2013
Q3 | $329K | Sell |
2,800
-7,000
| -71% | -$826K | ﹤0.01% | 1162 |
|
|
2013
Q2 | $1.1M | Buy |
+9,800
| New | +$1.15M | ﹤0.01% | 989 |
|
Other funds holding BIO
VAM
AI
FPA
Schroder Investment Management Group's BIO Position: Q2 2025 in Review
Schroder Investment Management Group sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 3,611 shares — an estimated $877K sold.
Schroder Investment Management Group first reported a position in BIO in Q2 2013 and held it in 34 quarters. The position peaked at $5.28M in Q3 2017. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.
- Schroder Investment Management Group reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
- Schroder Investment Management Group sold 3,611 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $877K.
- Schroder Investment Management Group first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 34 quarters.
- Schroder Investment Management Group's Bio-Rad Laboratories Class A position peaked at $5.28M in Q3 2017.
- 384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.
Based on Schroder Investment Management Group's 13F filing for Q2 2025, filed 13 Aug 2025.